These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15880304)

  • 1. [Pharmacotherapy in personality disorders].
    Wedekind D; Bandelow B; Rüther E
    Fortschr Neurol Psychiatr; 2005 May; 73(5):259-67. PubMed ID: 15880304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy of personality disorders: conceptual framework and clinical strategies.
    Gitlin MJ
    J Clin Psychopharmacol; 1993 Oct; 13(5):343-53. PubMed ID: 8227492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Psychopharmacologic treatment of personality disorders].
    Quante A; Röpke S; Merkl A; Anghelescu I; Lammers CH
    Fortschr Neurol Psychiatr; 2008 Mar; 76(3):139-48. PubMed ID: 18240112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy in personality disorders.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2007 Jun; 45(6):15-9. PubMed ID: 17601155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacotherapy in personality disorders: methodological issues and results].
    Pelissolo A; Lepine JP
    Encephale; 1999; 25(5):496-507. PubMed ID: 10598315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The psychopharmacologic treatment of personality disorders.
    Klar H; Siever LJ
    Psychiatr Clin North Am; 1984 Dec; 7(4):791-801. PubMed ID: 6151648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychopharmacologic approaches to the borderline patient.
    Zisook S; Ricketts JE
    Hillside J Clin Psychiatry; 1988; 10(1):55-70. PubMed ID: 2900799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Special feature: pharmacotherapy in personality disorders.
    Kapfhammer HP; Hippius H
    J Pers Disord; 1998; 12(3):277-88. PubMed ID: 9785268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychopharmacological treatment of non-comorbid and comorbid pervasive developmental disorder and pediatric bipolar disorder.
    Hamrin V; McDonnell MA; Moffett J; Durso S
    Minerva Pediatr; 2008 Feb; 60(1):87-101. PubMed ID: 18277368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy for personality disorders.
    Hori A
    Psychiatry Clin Neurosci; 1998 Feb; 52(1):13-9. PubMed ID: 9682928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug therapy of patients with emotionally unstable personality].
    Nissen T
    Tidsskr Nor Laegeforen; 2000 Aug; 120(18):2135-41. PubMed ID: 11006733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy of borderline states.
    Brinkley JR
    Psychiatr Clin North Am; 1993 Dec; 16(4):853-84. PubMed ID: 7906031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Algorithms for pharmacological treatment of personality dimensions: symptom-specific treatments for cognitive-perceptual, affective, and impulsive-behavioral dysregulation.
    Soloff PH
    Bull Menninger Clin; 1998; 62(2):195-214. PubMed ID: 9604516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.
    Mazza M; Mandelli L; Di Nicola M; Harnic D; Catalano V; Tedeschi D; Martinotti G; Colombo R; Bria P; Serretti A; Janiri L
    J Affect Disord; 2009 May; 115(1-2):27-35. PubMed ID: 18845344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric bipolar disorder: evidence-based psychopharmacological treatments.
    Hamrin V; Pachler M
    J Child Adolesc Psychiatr Nurs; 2007 Feb; 20(1):40-58. PubMed ID: 17284237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Psychopharmacological combination therapy in bipolar disorder].
    Quante A; van Hall F; Anghelescu I
    Fortschr Neurol Psychiatr; 2009 May; 77(5):252-62. PubMed ID: 19418383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication prescribed to people with personality disorder: the influence of patient factors and treatment setting.
    Crawford MJ; Kakad S; Rendel C; Mansour NA; Crugel M; Liu KW; Paton C; Barnes TR
    Acta Psychiatr Scand; 2011 Nov; 124(5):396-402. PubMed ID: 21707555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affective instability as rapid cycling: theoretical and clinical implications for borderline personality and bipolar spectrum disorders.
    Mackinnon DF; Pies R
    Bipolar Disord; 2006 Feb; 8(1):1-14. PubMed ID: 16411976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of depressive disorder and comorbid personality pathology: combined therapy versus pharmacotherapy].
    Kool S; Schoevers R; Duijsens IJ; Peen J; van Aalst G; de Jonghe F; Dekker J
    Tijdschr Psychiatr; 2007; 49(6):361-72. PubMed ID: 17611937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.